Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001947975-25-000019
Filing Date
2025-10-28
Accepted
2025-10-28 18:43:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11747
2 ex1.htm EX-1 7331
  Complete submission text file 0001947975-25-000019.txt   20933
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Subject) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90044 | Film No.: 251426342
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1 PENNSYLVANIA PLAZA SUITE 4810 NEW YORK NY 10119
Business Address 1 PENNSYLVANIA PLAZA SUITE 4810 NEW YORK NY 10119 646-975-5542
ATW Partners Opportunities Management, LLC (Filed by) CIK: 0001947975 (see all company filings)

EIN.: 851403360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G